Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
MORF

MORF - Morphic Holding Inc Stock Price, Fair Value and News

26.16USD+0.04 (+0.15%)Market Closed

Market Summary

MORF
USD26.16+0.04
Market Closed
0.15%

MORF Stock Price

View Fullscreen

MORF RSI Chart

MORF Valuation

Market Cap

1.3B

Price/Earnings (Trailing)

-8.13

Price/Sales (Trailing)

2.5K

EV/EBITDA

-7.93

Price/Free Cashflow

-10.19

MORF Price/Sales (Trailing)

MORF Profitability

EBT Margin

-30868.71%

Return on Equity

-24.3%

Return on Assets

-23.62%

Free Cashflow Yield

-9.81%

MORF Fundamentals

MORF Revenue

Revenue (TTM)

521.0K

Rev. Growth (Yr)

-100%

Rev. Growth (Qtr)

-100%

MORF Earnings

Earnings (TTM)

-161.3M

Earnings Growth (Yr)

-25.35%

Earnings Growth (Qtr)

-11.19%

Breaking Down MORF Revenue

Last 7 days

-7.2%

Last 30 days

-10.5%

Last 90 days

-24.4%

Trailing 12 Months

-55.3%

How does MORF drawdown profile look like?

MORF Financial Health

Current Ratio

38.17

MORF Investor Care

Shares Dilution (1Y)

26.21%

Diluted EPS (TTM)

-3.55

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20240000
202353.2M35.7M18.1M521.0K
202232.5M45.3M58.1M70.8M
202142.6M38.8M16.1M19.8M
202024.0M31.0M38.0M44.9M
20199.1M14.9M20.7M17.0M
20180003.4M

Tracking the Latest Insider Buys and Sells of Morphic Holding Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 27, 2024
rogers bruce
acquired
31,931
4.3151
7,400
president
Jan 16, 2024
rogers bruce
sold
-173,576
27.4907
-6,314
president
Jan 16, 2024
schegerin marc
sold
-166,071
27.4907
-6,041
cfo and coo
Jan 16, 2024
farrell robert e jr
sold
-139,900
27.4907
-5,089
svp finance and cao
Jan 16, 2024
tipirneni praveen p.
sold
-382,753
27.4907
-13,923
ceo
Jan 16, 2024
devaul william
sold
-123,956
27.4907
-4,509
general counsel and secretary
Jan 14, 2024
rogers bruce
acquired
-
-
5,070
president
Jan 14, 2024
tipirneni praveen p.
acquired
-
-
12,500
ceo
Jan 14, 2024
schegerin marc
acquired
-
-
4,690
cfo and coo
Jan 14, 2024
devaul william
acquired
-
-
3,250
general counsel and secretary

1–10 of 50

Which funds bought or sold MORF recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jun 04, 2024
DekaBank Deutsche Girozentrale
unchanged
-
62,000
441,000
-%
May 28, 2024
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
added
14.82
172,000
604,000
-%
May 21, 2024
China Universal Asset Management Co., Ltd.
added
67.39
172,976
338,976
0.04%
May 21, 2024
LRI Investments, LLC
new
-
35,200
35,200
0.01%
May 17, 2024
Artal Group S.A.
added
3.51
16,153,200
77,904,200
1.99%
May 16, 2024
JANE STREET GROUP, LLC
reduced
-54.89
-1,324,660
1,617,860
-%
May 16, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-3.11
165,416
1,079,900
-%
May 15, 2024
Industrial Alliance Investment Management Inc.
sold off
-100
-53,000
-
-%
May 15, 2024
Atom Investors LP
added
17.53
920,718
3,049,380
0.38%
May 15, 2024
Walleye Capital LLC
sold off
-100
-310,951
-
-%

1–10 of 46

Are Funds Buying or Selling MORF?

Are funds buying MORF calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own MORF
No. of Funds

Unveiling Morphic Holding Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
May 03, 2024
ecor1 capital, llc
6.0%
3,014,752
SC 13G
Feb 14, 2024
ecor1 capital, llc
0.4%
211,262
SC 13G/A
Feb 14, 2024
point72 asset management, l.p.
9.2%
4,591,000
SC 13G/A
Feb 14, 2024
ecor1 capital, llc
0.4%
211,262
SC 13G/A
Feb 09, 2024
fmr llc
-
0
SC 13G/A
Feb 09, 2024
polaris partners vii, l.p.
3.7%
1,860,498
SC 13G/A
Feb 09, 2024
artal international s.c.a.
4.3%
2,138,188
SC 13G/A
Feb 08, 2024
wellington management group llp
6.79%
3,377,310
SC 13G
Jan 26, 2024
blackrock inc.
6.6%
3,302,686
SC 13G/A
Jan 24, 2024
state street corp
5.15%
2,564,058
SC 13G

Recent SEC filings of Morphic Holding Inc

View All Filings
Date Filed Form Type Document
Jun 05, 2024
4
Insider Trading
Jun 05, 2024
4
Insider Trading
Jun 05, 2024
4
Insider Trading
Jun 05, 2024
4
Insider Trading
Jun 05, 2024
4
Insider Trading
Jun 05, 2024
4
Insider Trading
Jun 05, 2024
4
Insider Trading
Jun 05, 2024
4
Insider Trading
Jun 05, 2024
8-K
Current Report
May 03, 2024
SC 13G
Major Ownership Report

Peers (Alternatives to Morphic Holding Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
51.1B
6.8B
0.28% 3.53%
-8.56
7.46
-64.45% -224.75%
22.5B
216.3K
-0.77% 465779.94%
-2.5K
104.0K
- -8.13%
19.5B
2.0B
2.99% -23.67%
-58.61
9.71
75.20% 68.82%
16.0B
2.5B
8.50% -12.61%
77.77
6.46
13.74% 186.89%
13.8B
3.8B
7.60% -2.83%
18.51
3.66
8.58% 129.81%
MID-CAP
5.2B
107.9M
-8.24% 83.94%
-9.45
48.09
54.84% -28.31%
4.9B
524.1M
-2.95% -55.09%
-11.65
9.28
394.93% 39.61%
3.6B
251.0M
-0.68% -10.56%
-12.18
14.38
73.58% -86.73%
2.9B
240.7M
-4.80% -33.39%
-6.19
12.77
-1.03% -213.92%
2.5B
813.8M
0.54% -38.22%
-1.4K
3.02
56.43% 98.83%
1.9B
996.6M
5.92% 71.39%
-4.85
1.94
-26.66% 65.49%
SMALL-CAP
1.8B
411.3M
-9.22% 22.70%
27.15
4.3
60.38% -34.49%
468.2M
881.7K
-2.64% 488.84%
-13.87
481.06
-77.61% 33.36%
221.8M
4.2M
-28.67% 45.58%
-1.78
53.32
-66.30% 48.24%
19.9M
2.1M
16.67% 230.00%
-0.86
7.61
-13.45% 69.54%

Morphic Holding Inc News

Latest updates
Yahoo Sport Australia16 Jun 202410:32 pm
Defense World14 Jun 202403:53 pm
MarketBeat12 Jun 202407:46 pm

Morphic Holding Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue---1,533,7503,067,5004,601,2506,135,0002,055,00060,236,00034,896,2509,556,5003,124,0003,848,0003,265,0005,901,00025,757,0007,693,0005,594,0005,634,5005,675,0005,567,0006,068,000
Costs and Expenses8.4%53,604,00049,431,00044,748,00045,302,00039,726,00032,716,00033,548,00033,886,00034,054,00031,101,50028,242,00031,691,00024,566,00023,880,00020,749,00024,113,00023,383,00020,246,00015,533,00015,984,00012,202,000
  S&GA Expenses16.5%11,163,0009,579,00010,384,0009,583,0009,277,0008,014,0008,303,0008,234,0007,591,0007,443,5007,276,0007,139,0005,953,0005,126,5004,751,0004,195,0004,423,0003,426,0002,898,0002,077,0001,832,000
  R&D Expenses6.5%42,441,00039,852,00034,364,00035,719,00030,449,00024,702,00025,245,00025,652,00026,463,00023,658,00020,966,00024,552,00018,613,00018,753,50015,998,00019,918,00018,960,00016,820,00012,635,00013,907,00010,370,000
EBITDA Margin-6.0%-306-289-7.43-3.60-1.18-0.82-0.95-1.10-3.22-4.77-5.64-1.57---------
Income Taxes-37.0%80,000127,00083,000138,00032,00036,00029,0002,000------143,000-115,000-155,000-157,000344,000304,000135,000129,000
Earnings Before Taxes-11.3%-45,214,000-40,608,000-36,129,000-38,875,000-36,103,000-24,341,000-29,992,00026,843,000-31,484,000-21,402,000-25,041,000-27,815,000-21,284,000-17,892,0005,239,000-16,013,000-16,903,000-19,487,500-8,560,000-9,298,000-5,071,000
EBT Margin-6.0%-308-291-7.49-3.63-1.19-0.83-0.97-1.13-3.25-4.83-5.70-1.59---------
Net Income-11.2%-45,294,000-40,735,000-36,212,000-39,013,000-36,135,000-24,377,000-30,021,00026,841,000-31,484,000-21,402,000-25,041,000-27,815,000-21,284,000-17,749,0005,354,000-15,858,000-16,746,000-19,831,000-8,864,000-9,433,000-5,200,000
Net Income Margin-6.0%-309-291-7.50-3.63-1.20-0.83-0.97-1.13-3.25-4.83-5.69-1.59---------
Free Cashflow-64.2%-47,063,000-28,667,000-29,555,000-23,327,000-32,004,000-25,182,000-25,143,000-22,821,000-28,196,000-21,042,000-24,936,000-18,062,000---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22018Q4
Assets-5.5%683723744749442369389414397426439439460242222212229247260179189
  Current Assets-5.7%676717738743436362382407389418435437457239218209226244257173187
    Cash Equivalents-24.2%44.0059.0074.0021742.0060.0085.0014112017118439939610298.0013310710216044.00186
  Net PPE-0.6%3.003.002.003.002.002.002.002.002.003.003.002.002.003.003.003.003.003.003.003.002.00
Liabilities-24.7%19.0025.0020.0019.0015.0019.0024.0026.0084.0090.0088.0092.0091.0097.0091.0097.00101107101105102
  Current Liabilities-28.5%18.0025.0019.0018.0013.0017.0019.0020.0044.0038.0042.0035.0034.0039.0036.0045.0037.0035.0026.0044.0035.00
Shareholder's Equity-4.8%664697723729427349365388313337350348369145130115128141159--
  Retained Earnings-10.1%-494-449-408-372-333-297-272-242-269-238-216-191-163-142-124-130-114-97.51-77.68-68.82-54.18
  Additional Paid-In Capital1.3%1,1581,1441,1331,1047616506426335855755675405332882552452422382373.002.00
Shares Outstanding0.7%50.0050.0050.0048.0040.0039.0038.0038.0037.0036.0035.0035.00---------
Float----2,140---559---1,018---318---374-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-62.3%-46,389-28,574-29,250-23,034-31,454-25,118-24,894-22,817-28,148-20,585-24,578-17,908-20,390-14,4183,731-16,360-18,943-14,075-13,696-14,068188
  Share Based Compensation27.2%13,37510,51810,53410,3159,5767,1237,5377,6236,7655,6435,7915,3084,4423,0242,9962,4892,5441,377989667499
Cashflow From Investing143.4%31,36712,885-133,082-133,217-88,401-1,146-32,5093,278-26,0745,186-211,96119,84673,749-11,295-46,05141,91123,616-44,20134,20417,681-143,670
Cashflow From Financing2579.4%91134.0019,288331,626102,4845751,18140,8802,6302,67421,5791,481240,57929,6807,27953580328.0095,100--
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

MORF Income Statement

2024-03-31
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]  
Collaboration revenue$ 0$ 521
Operating expenses:  
Research and development42,44130,449
General and administrative11,1639,277
Total operating expenses53,60439,726
Loss from operations(53,604)(39,205)
Other income:  
Interest income, net8,3903,100
Other income, net02
Total other income, net8,3903,102
Loss before provision for income taxes(45,214)(36,103)
Provision for income taxes(80)(32)
Net loss$ (45,294)$ (36,135)
Net loss per share, basic (in dollars per share)$ (0.91)$ (0.90)
Net loss per share, diluted (in dollars per share)$ (0.91)$ (0.90)
Weighted average common shares outstanding, basic (in shares)50,009,03240,112,416
Weighted average common shares outstanding, diluted (in shares)50,009,03240,112,416
Comprehensive loss:  
Net loss$ (45,294)$ (36,135)
Other comprehensive (loss) income :  
Unrealized holding (losses) gains on marketable securities, net of tax(2,519)1,651
Total other comprehensive (loss) income(2,519)1,651
Comprehensive loss$ (47,813)$ (34,484)

MORF Balance Sheet

2024-03-31
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash and cash equivalents$ 44,410$ 58,577
Marketable securities614,356645,772
Prepaid expenses and other current assets17,17512,579
Total current assets675,941716,928
Operating lease right-of-use assets3,1012,133
Property and equipment, net2,7502,767
Restricted cash616560
Other assets357126
Total assets682,765722,514
Current liabilities:  
Accounts payable5,7487,698
Accrued expenses11,96317,078
Total current liabilities17,71124,776
Long-term liabilities:  
Operating lease liability, net of current portion1,474716
Total liabilities19,18525,492
Commitments and contingencies (Note 9)
Stockholders’ Equity  
Preferred shares, $0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2024 and December 31, 202300
Common shares, $0.0001 par value, 400,000,000 shares authorized, 50,093,588 shares issued and outstanding as of March 31, 2024 and 49,747,286 shares issued and outstanding as of December 31, 202355
Additional paid‑in capital1,158,2901,143,919
Accumulated deficit(494,484)(449,190)
Accumulated other comprehensive (loss) income(231)2,288
Total stockholders’ equity663,580697,022
Total liabilities and stockholders’ equity$ 682,765$ 722,514
MORF
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer. Its lead product candidate MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation is in Phase 2 clinical trials for the treatment of inflammatory bowel disease. The company's products in pipeline include Next Gen a4ß7 Inhibitors for additional potential GI indications, such as EGIDs, pouchitis, etc.; avß8 for the treatment of Myelofibrosis and solid tumor; and fibronectin integrin for pulmonary hypertensive. In addition, it has a license agreement with Janssen to discover and develop novel integrin therapeutics; collaboration agreement with Schrödinger for integrin targets; and license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
 CEO
 WEBSITEmorphictx.com
 INDUSTRYBiotechnology
 EMPLOYEES110

Morphic Holding Inc Frequently Asked Questions


What is the ticker symbol for Morphic Holding Inc? What does MORF stand for in stocks?

MORF is the stock ticker symbol of Morphic Holding Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Morphic Holding Inc (MORF)?

As of Tue Jun 18 2024, market cap of Morphic Holding Inc is 1.31 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MORF stock?

You can check MORF's fair value in chart for subscribers.

What is the fair value of MORF stock?

You can check MORF's fair value in chart for subscribers. The fair value of Morphic Holding Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Morphic Holding Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for MORF so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Morphic Holding Inc a good stock to buy?

The fair value guage provides a quick view whether MORF is over valued or under valued. Whether Morphic Holding Inc is cheap or expensive depends on the assumptions which impact Morphic Holding Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MORF.

What is Morphic Holding Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Jun 18 2024, MORF's PE ratio (Price to Earnings) is -8.13 and Price to Sales (PS) ratio is 2.52 Thousand. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MORF PE ratio will change depending on the future growth rate expectations of investors.